Latest Breaking News On - Horizon therapeutics - Page 7 : comparemela.com

Et voilà! New name takes top spot in reputation ranking by US patient groups

Et voilà! New name takes top spot in reputation ranking by US patient groups
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Gilead sciencesHorizon therapeuticsWith amgenViiv healthcare

Amgen Is Working On a Wegovy Competitor -- What It Means for Investors

Amgen Is Working On a Wegovy Competitor -- What It Means for Investors
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Robert bradwayNovo nordiskHorizon therapeuticsMotley fool stock advisorStock advisorservice

Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders

Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesCity ofUnited kingdomEric greenAnita scheuberMichael harveyMax bayerAndrew baumMarc beckerDanielle meyrickMichael chenSteve labkoffJulie oshaughnessyShephard mpofuStacy lindborg

Will Amgen Stock Continue To See Higher Levels Driven By Its Obesity Injection?

Will Amgen Stock Continue To See Higher Levels Driven By Its Obesity Injection?
forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.

Abbvie humiraHealth careTrefis high quality portfolioHorizon therapeutics

Amgen shares pop 12% after excitement from obesity drug candidate | Pacific Coast Business Times

Amgen's new research and development facility in San Francisco. (courtesy photo) Shares of Thousand Oaks-based Amgen gained 12% on May 3, one day after the company disclosed its earnings for the first quarter of 2024 and highlighted the excitement around its weight-loss drug. During the company’s earnings call, Amgen CEO Bob Bradway commented on their

San franciscoUnited statesBob bradwayJames bradnerWilliam blairMorgan stanleyJorge mercado mondayThousand oaks based amgenChief scientific officer james bradnerHorizon therapeuticsZacks consensusCentral coastLatest newsSubscriber contentTop storiesTop story